Products
Biosimilars
- NameHerzuma®
-
- INNTrastuzumab
- IndicationsOncology
- Pharmac Funding -
- Approved By Data Sheet Consumer Medicine Information (CMI) Herzuma webpage
- NameRemsima® SC
-
- INNInfliximab
- IndicationsGastroenterology, Rheumatology, Dermatology
- Pharmac Funding -
- Approved By Data Sheet Consumer Medicine Information (CMI)
- NameYuflyma®
-
- INNAdalimumab
- IndicationsGastroenterology, Rheumatology, Dermatology
- Pharmac Funding -
- Approved By Data Sheet Consumer Medicine Information (CMI)
- NameVegzelma®
-
- INNBevacizumab
- IndicationsOncology
- Pharmac Funding -
- Approved By Data Sheet Consumer Medicine Information (CMI) Vegzelma webpage
- NameOmlyclo®
-
- INNOmalizumab
- IndicationsRespiratory, Dermatology
- Pharmac Funding -
- Approved By
This product description is for medical and educational purposes only and not intended to promote the product.
For more details on the risks and benefits, please consult a doctor or healthcare professional.
For adverse events, product quality feedback or medical enquiries,
please contact Celltrion Healthcare New Zealand by emailing
medinfo-nz@celltrionhc.com or calling
0800 838 899
INN, international non-proprietary name
Novel Therapeutics
This product description is for medical and educational purposes only and not intended to promote the product.
For more details on the risks and benefits, please consult a doctor or healthcare professional.
For adverse events, product quality feedback or medical enquiries,
please contact Celltrion Healthcare New Zealand by emailing
medinfo-nz@celltrionhc.com or calling
0800 838 899
INN, international non-proprietary name